The U.S. stock market anomaly | The sale of GlucoTrack(GCTK.US) common stocks worth up to $20 million soared over 123%.

Chinatimes Finance App learned that on Friday, GlucoTrack (GCTK.US) soared over 123% to $10.91. In terms of news, GlucoTrack announced on September 11, 2025, that they had reached an agreement with Sixth Area Capital to sell up to $20 million in common stock. GlucoTrack's main business is the development of implantable continuous blood glucose monitoring devices, which directly measure blood glucose in real time, eliminating lag time and suitable for diabetes patients.